Product
DWC202207
1 clinical trial
2 indications
Indication
HypertensionIndication
HyperlipidemiaClinical trial
A Randomized, Double-blind, Multicenter Phase 3 Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Hypertension and DyslipidemiaStatus: Not yet recruiting, Estimated PCD: 2024-03-01